/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
Once a stock market darling, the pharma company is bearing the brunt of a costly acquisition.
Mankind Pharma finds itself in a bind. Once the darling of India’s pharmaceutical sector, the maker of over-the-counter brands such as Manforce, Prega News, Gas-O-Fast and AcneStar is suddenly facing a long, uncomfortable downturn.
In the first week of November, Mankind reported a 21.75% year-on-year dip in net profit to Rs 511.51 crore for the second quarter of 2025-26—its fourth straight decline. Extended monsoons and GST rate changes were blamed for the dent in performance, but investors saw something deeper amiss. The stock tumbled for five consecutive sessions.
Even the company’s management admitted as much. “Let me be very, very …
The food and FMCG giant is set to be put into provisional liquidation. Abu Dhabi’s IHC and Emaar founder Mohamed Alabbar are now eyeing it.
There’s something for both pessimists and optimists in the QSR player’s Q3 results. Right now, it looks like a coin toss where this business will go next, which makes the euphoric market reaction seem out of place.
Co-founder Lisa Suwal talks about how she scaled a family deli-meat business without a single rupee of venture capital and her decision to sell to ITC.
